KOBV Portal

1

Online Resource

Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study

Holbrook, Janet T. ; Sugar, Elizabeth A. ; Burke, Alyce E. ; [et al.]

Elsevier BV ; 2016

In: American Journal of Ophthalmology Vol. 164 ( 2016-04), p. 29-36

add to watchlist on the watchlist

Details

In: American Journal of Ophthalmology, Elsevier BV, Vol. 164 ( 2016-04), p. 29-36

Type of Medium: Online Resource

ISSN: 0002-9394

URL: Article

DOI: 10.1016/j.ajo.2015.12.028

RVK:

XA 19500

RVK:

XA 10000

Language: English

Publisher: Elsevier BV

Publication Date: 2016

detail.hit.zdb_id: 2019600-3

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Online Resource

Open Access Request

Availability (electronic / print)

BTU Cottbus

2

Online Resource

Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial

Kempen, John H. ; Van Natta, Mark L. ; Altaweel, Michael M. ; [et al.]

Elsevier BV ; 2015

In: American Journal of Ophthalmology Vol. 160, No. 6 ( 2015-12), p. 1133-1141.e9

add to watchlist on the watchlist

Details

In: American Journal of Ophthalmology, Elsevier BV, Vol. 160, No. 6 ( 2015-12), p. 1133-1141.e9

Type of Medium: Online Resource

ISSN: 0002-9394

URL: Article

DOI: 10.1016/j.ajo.2015.09.017

RVK:

XA 19500

RVK:

XA 10000

Language: English

Publisher: Elsevier BV

Publication Date: 2015

detail.hit.zdb_id: 2019600-3

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Online Resource

Open Access Request

Availability (electronic / print)

BTU Cottbus

3

Online Resource

Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for Uveitis

Kelly, Nicole K. ; Chattopadhyay, Aheli ; Rathinam, S.R. ; [et al.]

Elsevier BV ; 2021

In: Ophthalmology Vol. 128, No. 9 ( 2021-09), p. 1337-1345

add to watchlist on the watchlist

Details

In: Ophthalmology, Elsevier BV, Vol. 128, No. 9 ( 2021-09), p. 1337-1345

Type of Medium: Online Resource

ISSN: 0161-6420

URL: Article

DOI: 10.1016/j.ophtha.2021.02.024

RVK:

XA 10000

Language: English

Publisher: Elsevier BV

Publication Date: 2021

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Online Resource

Open Access Request

Availability (electronic / print)

4

Online Resource

Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST—Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial

Acharya, Nisha R. ; Ebert, Caleb D. ; Kelly, Nicole K. ; [et al.]

Springer Science and Business Media LLC ; 2020

In: Trials Vol. 21, No. 1 ( 2020-12)

add to watchlist on the watchlist

Details

In: Trials, Springer Science and Business Media LLC, Vol. 21, No. 1 ( 2020-12)

Abstract: Juvenile idiopathic arthritis (JIA)-associated uveitis is a chronic paediatric ocular inflammatory condition that can result in visual impairment. Adalimumab, a tumour necrosis factor (TNF)-alpha inhibitor, effectively controls joint and eye inflammation; however, its long-term use may increase the risk of adverse health outcomes and place an undue financial burden on the patient and healthcare system given its high cost. There is great interest for patients to stop adalimumab following remission due to these reasons but there is a lack of information on the ability to maintain control after discontinuing adalimumab. Methods The Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Trial (ADJUST) is a multicentred, international trial that will randomise 118 participants aged 2 years and older with controlled JIA-associated uveitis to either continue adalimumab or discontinue adalimumab and receive a placebo. The trial will compare the time to uveitis recurrence between the two groups over 12 months. All participants will receive the standard weight-based dose of adalimumab or placebo: 20 mg biweekly (if 〈 30 kg) or 40 mg biweekly (if ≥ 30 kg). Discussion This is the first randomised controlled trial to assess the efficacy of discontinuing adalimumab after demonstrating control of JIA-associated uveitis for at least 12 months. The results of ADJUST will provide information on clinical outcomes to guide clinicians in their decision-making regarding discontinuation of adalimumab. Trial registration ClinicalTrials.gov NCT03816397. Registered on 25 January 2019. EudraCT 2019-000412-29. Registered on 17 January 2019

Type of Medium: Online Resource

ISSN: 1745-6215

URL: Article

DOI: 10.1186/s13063-020-04796-z

Language: English

Publisher: Springer Science and Business Media LLC

Publication Date: 2020

detail.hit.zdb_id: 2040523-6

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Online Resource

Open Access Request

Availability (electronic / print)

BTU Cottbus

Wissenschaftspark Albert Einstein

EUV Frankfurt

TH Wildau

FH Potsdam

5

Online Resource

Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis

Suhler, Eric B. ; Jaffe, Glenn J. ; Fortin, Eric ; [et al.]

Elsevier BV ; 2021

In: Ophthalmology Vol. 128, No. 6 ( 2021-06), p. 899-909

add to watchlist on the watchlist

Details

In: Ophthalmology, Elsevier BV, Vol. 128, No. 6 ( 2021-06), p. 899-909

Type of Medium: Online Resource

ISSN: 0161-6420

URL: Article

DOI: 10.1016/j.ophtha.2020.10.036

RVK:

XA 10000

Language: English

Publisher: Elsevier BV

Publication Date: 2021

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Online Resource

Open Access Request

Availability (electronic / print)

6

Online Resource

Hypertension and the eye

DellaCroce, John T ; Vitale, Albert T

Ovid Technologies (Wolters Kluwer Health) ; 2008

In: Current Opinion in Ophthalmology Vol. 19, No. 6 ( 2008-11), p. 493-498

add to watchlist on the watchlist

Details

In: Current Opinion in Ophthalmology, Ovid Technologies (Wolters Kluwer Health), Vol. 19, No. 6 ( 2008-11), p. 493-498

Type of Medium: Online Resource

ISSN: 1040-8738

URL: Article

DOI: 10.1097/ICU.0b013e3283129779

RVK:

XA 10000

Language: English

Publisher: Ovid Technologies (Wolters Kluwer Health)

Publication Date: 2008

detail.hit.zdb_id: 2026983-3

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Online Resource

Open Access Request

Availability (electronic / print)

BTU Cottbus

Wissenschaftspark Albert Einstein

EUV Frankfurt

TH Wildau

7

Online Resource

Intravitreal Therapy for Uveitic Macular Edema—Ranibizumab versus Methotrexate versus the Dexamethasone Implant

Acharya, Nisha R. ; Vitale, Albert T. ; Sugar, Elizabeth A. ; [et al.]

Elsevier BV ; 2023

In: Ophthalmology Vol. 130, No. 9 ( 2023-09), p. 914-923

add to watchlist on the watchlist

Details

In: Ophthalmology, Elsevier BV, Vol. 130, No. 9 ( 2023-09), p. 914-923

Type of Medium: Online Resource

ISSN: 0161-6420

URL: Article

DOI: 10.1016/j.ophtha.2023.04.011

RVK:

XA 10000

Language: English

Publisher: Elsevier BV

Publication Date: 2023

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Online Resource

Open Access Request

Availability (electronic / print)

8

Online Resource

Identifying RNA Biomarkers and Molecular Pathways Involved in Multiple Subtypes of Uveitis

Rosenbaum, James T. ; Harrington, Christina A. ; Searles, Robert P. ; [et al.]

Elsevier BV ; 2021

In: American Journal of Ophthalmology Vol. 226 ( 2021-06), p. 226-234

add to watchlist on the watchlist

Details

In: American Journal of Ophthalmology, Elsevier BV, Vol. 226 ( 2021-06), p. 226-234

Type of Medium: Online Resource

ISSN: 0002-9394

URL: Article

DOI: 10.1016/j.ajo.2021.01.007

RVK:

XA 19500

RVK:

XA 10000

Language: English

Publisher: Elsevier BV

Publication Date: 2021

detail.hit.zdb_id: 2019600-3

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Online Resource

Open Access Request

Availability (electronic / print)

BTU Cottbus

9

Online Resource

Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema

Thorne, Jennifer E. ; Sugar, Elizabeth A. ; Holbrook, Janet T. ; [et al.]

Elsevier BV ; 2019

In: Ophthalmology Vol. 126, No. 2 ( 2019-02), p. 283-295

add to watchlist on the watchlist

Details

In: Ophthalmology, Elsevier BV, Vol. 126, No. 2 ( 2019-02), p. 283-295

Type of Medium: Online Resource

ISSN: 0161-6420

URL: Article

DOI: 10.1016/j.ophtha.2018.08.021

RVK:

XA 10000

Language: English

Publisher: Elsevier BV

Publication Date: 2019

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Online Resource

Open Access Request

Availability (electronic / print)

10

Online Resource

Revising the Diagnosis of Idiopathic Uveitis by Peripheral Blood Transcriptomics

Rosenbaum, James T. ; Harrington, Christina A. ; Searles, Robert P. ; [et al.]

Elsevier BV ; 2021

In: American Journal of Ophthalmology Vol. 222 ( 2021-02), p. 15-23

add to watchlist on the watchlist

Details

In: American Journal of Ophthalmology, Elsevier BV, Vol. 222 ( 2021-02), p. 15-23

Type of Medium: Online Resource

ISSN: 0002-9394

URL: Article

DOI: 10.1016/j.ajo.2020.09.012

RVK:

XA 19500

RVK:

XA 10000

Language: English

Publisher: Elsevier BV

Publication Date: 2021

detail.hit.zdb_id: 2019600-3

Bookmarklink

Library	Location	Call Number	Volume/Issue/Year	Availability

Others were also interested in ...

Online Resource

Open Access Request

Availability (electronic / print)

BTU Cottbus

Kooperativer Bibliotheksverbund

Berlin Brandenburg